Malignancy Rate in Thyroid Nodules Classified as Bethesda Category III (AUS/FLUS): Is There a Correct Answer?

被引：11
|
作者：
Heller, Keith S. [1 ]
机构：
[1] NYU, Dept Surg, Sch Med, New York, NY 10016 USA
来源：
THYROID | 2014年 / 24卷 / 05期
关键词：
DIAGNOSIS;
D O I：
10.1089/thy.2014.0142
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：787 / 788
页数：2
相关论文
共 50 条
  • [1] Malignancy Rate in Thyroid Nodules Classified as Bethesda Category III (AUS/FLUS)
    Ho, Allen S.
    Sarti, Evan E.
    Jain, Kunal S.
    Wang, Hangjun
    Nixon, Iain J.
    Shaha, Ashok R.
    Shah, Jatin P.
    Kraus, Dennis H.
    Ghossein, Ronald
    Fish, Stephanie A.
    Wong, Richard J.
    Lin, Oscar
    Morris, Luc G. T.
    [J]. THYROID, 2014, 24 (05) : 832 - 839
  • [2] Risk factors associated with malignancy and with triage to surgery in thyroid nodules classified as Bethesda category III (AUS/FLUS)
    Kuru, B.
    Atmaca, A.
    Tarim, I. A.
    Kefeli, M.
    Topgul, K.
    Yoruker, S.
    Elmali, M.
    Danaci, M.
    [J]. EJSO, 2016, 42 (01): : 87 - 93
  • [3] Patient outcomes following surgical management of thyroid nodules classified as Bethesda category III (AUS/FLUS)
    Mulita, Francesk
    Plachouri, Maria-Kerasia
    Liolis, Elias
    Vailas, Michail
    Panagopoulos, Konstantinos
    Maroulis, Ioannis
    [J]. ENDOKRYNOLOGIA POLSKA, 2021, 72 (02) : 143 - 144
  • [4] The Prediction of Malignancy Risk in Thyroid Nodules Classified as Bethesda System Category III (AUS/FLUS) and the Role of Ultrasound Finding for Prediction of Malignancy Risk
    Alshahrani, Awad S.
    Alamri, Abdulrahman S.
    Balkhoyor, Abdulrahman H.
    Mahzari, Moeber M.
    Alshieban, Saeed S.
    Majed, Pharaon M.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
  • [5] Predictors of Malignancy in Thyroid Nodules Classified as Bethesda Category III
    Liu, Xiaoli
    Wang, Jingjing
    Du, Wei
    Dai, Liyuan
    Fang, Qigen
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [6] Evaluation of thyroid nodules classified as Bethesda category III on cytology and their malignancy rate:An institutional experience
    Almahari, Sayed Ali
    Harb, Zainab
    Alshaikh, Safa
    [J]. CYTOJOURNAL, 2019, 16
  • [7] Evidence for overestimation of the prevalence of malignancy in indeterminate thyroid nodules classified as Bethesda category III
    Iskandar, Mazen E.
    Bonomo, Giovanni
    Avadhani, Vaidehi
    Persky, Mark
    Lucido, David
    Wang, Beverly
    Marti, Jennifer L.
    [J]. SURGERY, 2015, 157 (03) : 510 - 517
  • [8] WHICH FACTORS ARE ASSOCIATED WITH MALIGNANCY IN THYROID NODULES CLASSIFIED AS BETHESDA CATEGORY 3 (AUS/FLUS) AND HOW DO THEY INFLUENCE THE PATIENT'S MANAGEMENT?
    Kaya, C.
    Bozkurt, E.
    Mut, D. Turkyilmaz
    Mihmanli, M.
    Uludag, M.
    [J]. ACTA ENDOCRINOLOGICA-BUCHAREST, 2019, 15 (04) : 491 - 496
  • [9] Evaluation of thyroid nodules classified as Bethesda category III on FNAC
    Garg, Shiwani
    Naik, Leena P.
    Kothari, Kanchan S.
    Fernandes, Gwendolyn C.
    Agnihotri, Mona A.
    Gokhale, Jagruti C.
    [J]. JOURNAL OF CYTOLOGY, 2017, 34 (01) : 5 - 9
  • [10] Diagnostic models for predicting malignancy in thyroid nodules classified as Bethesda Category III in an endemic region
    Kasap, Zeliha Aydin
    Kurt, Burcin
    Ozsagir, Elif
    Ercin, Mustafa Emre
    Guner, Ali
    [J]. DIAGNOSTIC CYTOPATHOLOGY, 2024, 52 (04) : 200 - 210
12345